Skip to search formSkip to main contentSkip to account menu

Triptorelin Acetate

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Background/Aims: To evaluate the efficacy and safety of a triptorelin pamoate (11.25 mg) 3-month formulation in the management of… 
2016
2016
Central precocious puberty (CPP) develops due to premature activation of the hypothalamic-pituitary-gonadal (HPG) axis, resulting… 
2015
2015
PurposeTo compare the efficacy of the oral dienogest versus triptorelin acetate injection for treatment of premenopausal… 
2014
2014
AbstractAimThe aim of this study was to compare the efficiency of dopamine agonist, Cabergoline, in decreasing the size of… 
2014
2014
AbstractTriptorelin, a gonadotropin-releasing hormone agonist, has been used in the treatment of hormone-responsive prostate… 
2013
2013
The GnRH test is the gold standard to confirm the diagnosis of central precocious puberty (CPP); however, this compound is not… 
Highly Cited
2007
Highly Cited
2007
Highly Cited
2000
Highly Cited
2000
Gonadotrophin-releasing hormone agonists (GnRHa) are routinely used in IVF programmes to prevent an unwanted LH surge and… 
1997
1997
AIMS Triptorelin is a gonadotropin-releasing hormone (GnRH) analogue with enhanced affinity for GnRH receptors and a prolonged…